The U.S. Food and Drug Administration has asked a federal judge in Texas to throw out a public records lawsuit related to ...
The vaccine maker said the regulator placed the hold because of a report of a “serious adverse event” of motor neuropathy in ...
Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...
The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.
The FDA has approved emergency use of a third COVID-19 vaccine from Johnson & Johnson’s Janssen Biotech unit, the day after an advisory committee concluded it was safe and effective. Janssen’s ...
The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 ...
The clinical hold is due to a spontaneous report of a serious adverse event (SAE) of motor neuropathy in a single CIC Phase 2 trial participant outside the U.S. who received the vaccine in January ...
Wednesday said the U.S. Food and Drug Administration (FDA) has placed a clinical hold on its COVID-19-Influenza ...
Novavax announced that the U.S. Food and Drug Administration has placed a clinical hold on Novavax’s Investigational New Drug ...
A: Yes, for an anthrax vaccine (in 2005 ... Q: How many people does the FDA have working on COVID-19 vaccines? A: We have a review group that is set up and meets regularly.
Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined ...